HutchMED (China) LIMITED Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- HutchMED (China) LIMITED payments for repurchase of common stock for the quarter ending 2019-12-31 was $0.00.
- HutchMED (China) LIMITED payments for repurchase of common stock for the quarter ending 2019-09-30 was $0.00.
- HutchMED (China) LIMITED payments for repurchase of common stock for the quarter ending 2019-06-30 was $0.00.
- HutchMED (China) LIMITED payments for repurchase of common stock for the quarter ending 2019-03-31 was $346.00K, a 93.65% decline year-over-year.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2024-12-31 | $36.06M 20-F · filed 2026-03-05 | |
| 2023-12-31 | $9.07M 20-F · filed 2026-03-05 | |
| 2022-12-31 | $48.08M 20-F · filed 2025-03-19 | |
| 2021-12-31 | $27.31M 20-F · filed 2024-02-28 | |
| 2020-12-31 | $12.90M 20-F · filed 2023-02-28 | |
| 2019-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $346.00K 20-F · filed 2022-03-03 |
| 2019-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $346.00K derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $346.00K derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $346.00K 6-K · filed 2019-06-06 | $346.00K derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $5.45M 20-F · filed 2021-03-04 |
| 2018-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | |
| 2018-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | |
| 2018-03-31 | $5.45M 6-K · filed 2019-06-06 | |
| 2017-12-31 | $1.37M 20-F · filed 2020-03-03 | |
| 2016-12-31 | $604.00K 20-F · filed 2019-03-11 | |
| 2015-12-31 | $1.79M 20-F · filed 2018-03-12 |